Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain

Neurobiology of Aging

Volumn 35, Issue 6, 2014, Pages 1334-1344

  Coppieters, Natacha ^a   Dieriks, Birger V ^a   Lill, Claire ^a   Faull, Richard L M ^a   Curtis, Maurice A ^a   Dragunow, Mike ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

5 Hydroxymethylcytosine (5hmC); 5 Methylcytosine (5mC); Alzheimer's disease; DNA hydroxymethylation; DNA methylation; Epigenetics; Human brain

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; 5 METHYLCYTOSINE; AMYLOID BETA PROTEIN; TAU PROTEIN; 5-HYDROXYMETHYLCYTOSINE; CYTOSINE; GENETIC MARKER;

AGED; ALZHEIMER DISEASE; ANTIBODY LABELING; ARTICLE; ASTROCYTE; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DNA HYDROXYMETHYLATION; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROGLIA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; UBIQUITINATION; ANALOGS AND DERIVATIVES; DRUG EFFECTS; FEMALE; GENE EXPRESSION; GENETIC EPIGENESIS; GENETIC MARKER; GENETICS; MALE; METABOLISM; MIDDLE AGED; NERVE CELL; PARAHIPPOCAMPAL GYRUS; PATHOLOGY; PHYSIOLOGY; VERY ELDERLY;

5-METHYLCYTOSINE; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASTROCYTES; CYTOSINE; DISEASE PROGRESSION; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; GENETIC MARKERS; HUMANS; MALE; MICROGLIA; MIDDLE AGED; NEURONS; PARAHIPPOCAMPAL GYRUS;

EID: 84903362440     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.11.031     Document Type: Article

References (87)

1. Bakulski K.M., Dolinoy D.C., Sartor M.A., Paulson H.L., Konen J.R., Lieberman A.P., Albin R.L., Hu H., Rozek L.S. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J.Alzheimers Dis. 2012, 29:571-588.
2. Barrachina M., Ferrer I. DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain. J.Neuropathol. Exp. Neurol. 2009, 68:880-891.
3. Beach T.G., Tago H., Nagai T., Kimura H., McGeer P.L., McGeer E.G. Perfusion-fixation of the human brain for immunohistochemistry: comparison with immersion-fixation. J.Neurosci. Methods 1987, 19:183-192.
4. Bekris L.M., Yu C.E., Bird T.D., Tsuang D.W. Genetics of Alzheimer disease. J.Geriatr. Psychiatry Neurol. 2010, 23:213-227.
5. Bihaqi S.W., Schumacher A., Maloney B., Lahiri D.K., Zawia N.H. Do epigenetic pathways initiate late onset Alzheimer disease (LOAD): towards a new paradigm. Curr. Alzheimers Res. 2012, 9:574-588.
6. Bradley-Whitman M.A., Lovell M.A. Epigenetic changes in the progression of Alzheimer's disease. Mech. Ageing Dev. 2013, 134:486-495.
7. Chen H., Dzitoyeva S., Manev H. Effect of aging on 5-hydroxymethylcytosine in the mouse hippocampus. Restor. Neurol. Neurosci. 2012, 30:237-245.
8. Chestnut B.A., Chang Q., Price A., Lesuisse C., Wong M., Martin L.J. Epigenetic regulation of motor neuron cell death through DNA methylation. J.Neurosci. 2011, 31:16619-16636.
9. Chouliaras L., Mastroeni D., Delvaux E., Grover A., Kenis G., Hof P.R., Steinbusch H.W., Coleman P.D., Rutten B.P., van den Hove D.L. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol. Aging 2013, 34:2091-2099.
10. Chouliaras L., Rutten B.P., Kenis G., Peerbooms O., Visser P.J., Verhey F., van Os J., Steinbusch H.W., van den Hove D.L. Epigenetic regulation in the pathophysiology of Alzheimer's disease. Prog. Neurobiol. 2010, 90:498-510.
11. Chouliaras L., van den Hove D.L., Kenis G., Keitel S., Hof P.R., van Os J., Steinbusch H.W., Schmitz C., Rutten B.P. Age-related increase in levels of 5-hydroxymethylcytosine in mouse hippocampus is prevented by caloric restriction. Curr. Alzheimers Res. 2012, 9:536-544.
12. Chouliaras L., van den Hove D.L., Kenis G., Keitel S., Hof P.R., van Os J., Steinbusch H.W., Schmitz C., Rutten B.P. Prevention of age-related changes in hippocampal levels of 5-methylcytidine by caloric restriction. Neurobiol. Aging 2012, 33:1672-1681.
13. Collings C.K., Waddell P.J., Anderson J.N. Effects of DNA methylation on nucleosome stability. Nucleic Acids Res. 2013, 41:2918-2931.
14. Coppieters N., Dragunow M. Epigenetics in Alzheimer's disease: a focus on DNA modifications. Curr. Pharm. Des. 2011, 17:3398-3412.
15. Dahl C., Gronbaek K., Guldberg P. Advances in DNA methylation: 5-hydroxymethylcytosine revisited. Clin. Chim. Acta 2011, 412:831-836.
16. Day J.J., Sweatt J.D. Cognitive neuroepigenetics: a role for epigenetic mechanisms in learning and memory. Neurobiol. Learn Mem. 2011, 96:2-12.
17. Duyckaerts C., Delatour B., Potier M.C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009, 118:5-36.
18. Endres M., Fan G., Meisel A., Dirnagl U., Jaenisch R. Effects of cerebral ischemia in mice lacking DNA methyltransferase 1 in post-mitotic neurons. Neuroreport 2001, 12:3763-3766.
19. Endres M., Meisel A., Biniszkiewicz D., Namura S., Prass K., Ruscher K., Lipski A., Jaenisch R., Moskowitz M.A., Dirnagl U. DNA methyltransferase contributes to delayed ischemic brain injury. J.Neurosci. 2000, 20:3175-3181.
20. Fan G., Beard C., Chen R.Z., Csankovszki G., Sun Y., Siniaia M., Biniszkiewicz D., Bates B., Lee P.P., Kuhn R., Trumpp A., Poon C., Wilson C.B., Jaenisch R. DNA hypomethylation perturbs the function and survival of CNS neurons in postnatal animals. J.Neurosci. 2001, 21:788-797.
21. Ficz G., Branco M.R., Seisenberger S., Santos F., Krueger F., Hore T.A., Marques C.J., Andrews S., Reik W. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011, 473:398-402.
22. Finder V.H. Alzheimer's disease: a general introduction and pathomechanism. J.Alzheimers Dis. 2010, 22(suppl 3):5-19.
23. Fuso A., Nicolia V., Pasqualato A., Fiorenza M.T., Cavallaro R.A., Scarpa S. Changes in presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency. Neurobiol. Aging 2011, 32:187-199.
24. Garcia-Sierra F., Jarero-Basulto J.J., Kristofikova Z., Majer E., Binder L.I., Ripova D. Ubiquitin is associated with early truncation of tau protein at aspartic acid(421) during the maturation of neurofibrillary tangles in Alzheimer's disease. Brain Pathol. 2012, 22:240-250.
25. Gibbs J.R., van der Brug M.P., Hernandez D.G., Traynor B.J., Nalls M.A., Lai S.L., Arepalli S., Dillman A., Rafferty I.P., Troncoso J., Johnson R., Zielke H.R., Ferrucci L., Longo D.L., Cookson M.R., Singleton A.B. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 2010, 6:e1000952.
26. Globisch D., Munzel M., Muller M., Michalakis S., Wagner M., Koch S., Bruckl T., Biel M., Carell T. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One 2010, 5:e15367.
27. Gu Y., Nieves J.W., Stern Y., Luchsinger J.A., Scarmeas N. Food combination and Alzheimer disease risk: a protective diet. Arch. Neurol. 2010, 67:699-706.
28. Guo J.U., Su Y., Zhong C., Ming G.L., Song H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011, 145:423-434.
29. Hashimoto H., Liu Y., Upadhyay A.K., Chang Y., Howerton S.B., Vertino P.M., Zhang X., Cheng X. Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res. 2012, 40:4841-4849.
30. Hernandez D.G., Nalls M.A., Gibbs J.R., Arepalli S., van der Brug M., Chong S., Moore M., Longo D.L., Cookson M.R., Traynor B.J., Singleton A.B. Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum. Mol. Genet. 2011, 20:1164-1172.
31. Huang Y., Pastor W.A., Shen Y., Tahiliani M., Liu D.R., Rao A. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 2010, 5:e8888.
32. Hutnick L.K., Golshani P., Namihira M., Xue Z., Matynia A., Yang X.W., Silva A.J., Schweizer F.E., Fan G. DNA hypomethylation restricted to the murine forebrain induces cortical degeneration and impairs postnatal neuronal maturation. Hum. Mol. Genet. 2009, 18:2875-2888.
33. Ihara Y., Morishima-Kawashima M., Nixon R. The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease. Cold Spring Harb. Perspect Med. 2012, 2:a006361.
34. Ikonomovic M.D., Abrahamson E.E., Uz T., Manev H., Dekosky S.T. Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease. J.Histochem. Cytochem. 2008, 56:1065-1073.
35. Iqbal K., Flory M., Khatoon S., Soininen H., Pirttila T., Lehtovirta M., Alafuzoff I., Blennow K., Andreasen N., Vanmechelen E., Grundke-Iqbal I. Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers. Ann. Neurol. 2005, 58:748-757.
36. Iqbal K., Jin S.G., Pfeifer G.P., Szabo P.E. Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:3642-3647.
37. Ito S., D'Alessio A.C., Taranova O.V., Hong K., Sowers L.C., Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010, 466:1129-1133.
38. Iwamoto K., Bundo M., Ueda J., Oldham M.C., Ukai W., Hashimoto E., Saito T., Geschwind D.H., Kato T. Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Res. 2011, 21:688-696.
39. Jin S.G., Kadam S., Pfeifer G.P. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res. 2010, 38:e125.
40. Jin S.G., Wu X., Li A.X., Pfeifer G.P. Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res. 2011, 39:5015-5024.
41. Jurkowska R.Z., Jurkowski T.P., Jeltsch A. Structure and function of mammalian DNA methyltransferases. Chembiochem 2011, 12:206-222.
42. Kandimalla R.J., Prabhakar S., Binukumar B., Wani W.Y., Sharma D.R., Grover V.K., Bhardwaj N., Jain K., Gill K.D. Cerebrospinal fluid profile of amyloid beta42 (Abeta42), hTau and ubiquitin in North Indian Alzheimer's disease patients. Neurosci. Lett. 2011, 487:134-138.
43. Kubiura M., Okano M., Kimura H., Kawamura F., Tada M. Chromosome-wide regulation of euchromatin-specific 5mC to 5hmC conversion in mouse ES cells and female human somatic cells. Chromosome Res. 2012, 20:837-848.
44. Ladd-Acosta C., Pevsner J., Sabunciyan S., Yolken R.H., Webster M.J., Dinkins T., Callinan P.A., Fan J.B., Potash J.B., Feinberg A.P. DNA methylation signatures within the human brain. Am. J. Hum. Genet. 2007, 81:1304-1315.
45. Lahiri D.K., Maloney B., Zawia N.H. The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol. Psychiatry 2009, 14:992-1003.
46. Lavenex P., Lavenex P.B., Bennett J.L., Amaral D.G. Postmortem changes in the neuroanatomical characteristics of the primate brain: hippocampal formation. J.Comp. Neurol. 2009, 512:27-51.
47. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 2002, 3:662-673.
48. Lin J., Hou J.Q., Xiang H.D., Yan Y.Y., Gu Y.C., Tan J.H., Li D., Gu L.Q., Ou T.M., Huang Z.S. Stabilization of G-quadruplex DNA by C-5-methyl-cytosine in bcl-2 promoter: implications for epigenetic regulation. Biochem. Biophys. Res. Commun. 2013, 433:368-373.
49. Lister R., Pelizzola M., Dowen R.H., Hawkins R.D., Hon G., Tonti-Filippini J., Nery J.R., Lee L., Ye Z., Ngo Q.M., Edsall L., Antosiewicz-Bourget J., Stewart R., Ruotti V., Millar A.H., Thomson J.A., Ren B., Ecker J.R. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
50. Mastroeni D., Grover A., Delvaux E., Whiteside C., Coleman P.D., Rogers J. Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol. Aging 2010, 31:2025-2037.
51. Mausset-Bonnefont A.L., de Seze R., Privat A. Immunohistochemistry as a tool for topographical semi-quantification of neurotransmitters in the brain. Brain Res. Brain Res. Protoc 2003, 10:148-155.
52. Mazin A.L. Suicidal function of DNA methylation in age-related genome disintegration. Ageing Res. Rev. 2009, 8:314-327.
53. Mellen M., Ayata P., Dewell S., Kriaucionis S., Heintz N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 2012, 151:1417-1430.
54. Morgan A.R., Hamilton G., Turic D., Jehu L., Harold D., Abraham R., Hollingworth P., Moskvina V., Brayne C., Rubinsztein D.C., Lynch A., Lawlor B., Gill M., O'Donovan M., Powell J., Lovestone S., Williams J., Owen M.J. Association analysis of 528 intra-genic SNPs in a region of chromosome 10 linked to late onset Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B:727-731.
55. Morrison J.H., Hof P.R. Life and death of neurons in the aging brain. Science 1997, 278:412-419.
56. Munzel M., Globisch D., Bruckl T., Wagner M., Welzmiller V., Michalakis S., Muller M., Biel M., Carell T. Quantification of the sixth DNA base hydroxymethylcytosine in the brain. Angew. Chem. Int. Ed. Engl. 2010, 49:5375-5377.
57. Narayan P.J., Dragunow M. High content analysis of histone acetylation in human cells and tissues. J.Neurosci. Methods 2010, 193:54-61.
58. Nestor C., Ruzov A., Meehan R., Dunican D. Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques 2010, 48:317-319.
59. Nishioka M., Shimada T., Bundo M., Ukai W., Hashimoto E., Saito T., Kano Y., Sasaki T., Kasai K., Kato T., Iwamoto K. Neuronal cell-type specific DNA methylation patterns of the Cacna1c gene. Int. J. Dev. Neurosci. 2013, 31:89-95.
60. Orr B.A., Haffner M.C., Nelson W.G., Yegnasubramanian S., Eberhart C.G. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS One 2012, 7:e41036.
61. Padurariu M., Ciobica A., Mavroudis I., Fotiou D., Baloyannis S. Hippocampal neuronal loss in the CA1 and CA3 areas of Alzheimer's disease patients. Psychiatr. Danub. 2012, 24:152-158.
62. Perry G., Friedman R., Shaw G., Chau V. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:3033-3036.
63. Piyathilake C.J., Johanning G.L., Frost A.R., Whiteside M.A., Manne U., Grizzle W.E., Heimburger D.C., Niveleau A. Immunohistochemical evaluation of global DNA methylation: comparison with invitro radiolabeled methyl incorporation assay. Biotech. Histochem. 2000, 75:251-258.
64. Rao J.S., Keleshian V.L., Klein S., Rapoport S.I. Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients. Transl. Psychiatry 2012, 2:e132.
65. Reik W., Walter J. Genomic imprinting: parental influence on the genome. Nat. Rev. Genet. 2001, 2:21-32.
66. Rhee K.D., Yu J., Zhao C.Y., Fan G., Yang X.J. Dnmt1-dependent DNA methylation is essential for photoreceptor terminal differentiation and retinal neuron survival. Cell Death Dis. 2012, 3:e427.
67. Riederer B.M., Leuba G., Vernay A., Riederer I.M. The role of the ubiquitin proteasome system in Alzheimer's disease. Exp. Biol. Med. (Maywood) 2011, 236:268-276.
68. Rogaev E.I., Lukiw W.J., Lavrushina O., Rogaeva E.A., St George-Hyslop P.H. The upstream promoter of the beta-amyloid precursor protein gene (APP) shows differential patterns of methylation in human brain. Genomics 1994, 22:340-347.
69. Scarpa S., Fuso A., D'Anselmi F., Cavallaro R.A. Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease?. FEBS Lett. 2003, 541:145-148.
70. Severin P.M., Zou X., Schulten K., Gaub H.E. Effects of cytosine hydroxymethylation on DNA strand separation. Biophys. J. 2013, 104:208-215.
71. Siegmund K.D., Connor C.M., Campan M., Long T.I., Weisenberger D.J., Biniszkiewicz D., Jaenisch R., Laird P.W., Akbarian S. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS One 2007, 2:e895.
72. Song C.X., Szulwach K.E., Fu Y., Dai Q., Yi C., Li X., Li Y., Chen C.H., Zhang W., Jian X., Wang J., Zhang L., Looney T.J., Zhang B., Godley L.A., Hicks L.M., Lahn B.T., Jin P., He C. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 2010, 29:68-72.
73. Szulwach K.E., Li X., Li Y., Song C.X., Wu H., Dai Q., Irier H., Upadhyay A.K., Gearing M., Levey A.I., Vasanthakumar A., Godley L.A., Chang Q., Cheng X., He C., Jin P. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat. Neurosci. 2011, 14:1607-1616.
74. Szwagierczak A., Bultmann S., Schmidt C.S., Spada F., Leonhardt H. Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res. 2010, 38:e181.
75. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., Agarwal S., Iyer L.M., Liu D.R., Aravind L., Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
76. Tohgi H., Utsugisawa K., Nagane Y., Yoshimura M., Genda Y., Ukitsu M. Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex. Brain Res. Mol. Brain Res. 1999, 70:288-292.
77. Varley K.E., Gertz J., Bowling K.M., Parker S.L., Reddy T.E., Pauli-Behn F., Cross M.K., Williams B.A., Stamatoyannopoulos J.A., Crawford G.E., Absher D.M., Wold B.J., Myers R.M. Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res. 2013, 23:555-567.
78. Waldvogel H.J., Bullock J.Y., Synek B.J., Curtis M.A., van Roon-Mom W.M., Faull R.L. The collection and processing of human brain tissue for research. Cell Tissue Bank. 2008, 9:169-179.
79. Waldvogel H.J., Curtis M.A., Baer K., Rees M.I., Faull R.L. Immunohistochemical staining of post-mortem adult human brain sections. Nat. Protoc. 2006, 1:2719-2732.
80. Wang G.P., Khatoon S., Iqbal K., Grundke-Iqbal I. Brain ubiquitin is markedly elevated in Alzheimer disease. Brain Res. 1991, 566:146-151.
81. Wang S.C., Oelze B., Schumacher A. Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS One 2008, 3:e2698.
82. Weissman L., Jo D.G., Sorensen M.M., de Souza-Pinto N.C., Markesbery W.R., Mattson M.P., Bohr V.A. Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment. Nucleic Acids Res. 2007, 35:5545-5555.
83. West M.J., Coleman P.D., Flood D.G., Troncoso J.C. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994, 344:769-772.
84. West R.L., Lee J.M., Maroun L.E. Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patient. J.Mol. Neurosci. 1995, 6:141-146.
85. Wu J., Basha M.R., Brock B., Cox D.P., Cardozo-Pelaez F., McPherson C.A., Harry J., Rice D.C., Maloney B., Chen D., Lahiri D.K., Zawia N.H. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J.Neurosci. 2008, 28:3-9.
86. Yu M., Hon G.C., Szulwach K.E., Song C.X., Zhang L., Kim A., Li X., Dai Q., Shen Y., Park B., Min J.H., Jin P., Ren B., He C. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 2012, 149:1368-1380.
87. Zhang H., Zhang X., Clark E., Mulcahey M., Huang S., Shi Y.G. TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine. Cell Res. 2010, 20:1390-1393.